Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl
Development Commissioner (micro Small & Medium Enterprises)
Progress
Quantity
26917
Category
Title3
Bid Type
Two Packet Bid
Indian Army invites bids for Title1, Title2, Title3, Title4, Title5, Title6, Title7, Title8, Title9, Title10, Title11, Title12, Title13, Title14, Title15, Title16, Title17, Title18 in PATIALA, PUNJAB. Quantity: 26917. Submission Deadline: 18-01-2025 11: 00: 00. Submit your proposal before the deadline.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Title1 , Title2 , Title3 , Title4 , Title5 , Title6 , Title7 , Title8 , Title9 , Title10 , Title11 , Title12 , Title13 , Title14 , Title15 , Title16 , Title17 , Title18
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS
Development Commissioner (micro Small & Medium Enterprises)
Indian Army
JALPAIGURI, WEST BENGAL
Indian Air Force
SOUTH WEST DELHI, DELHI
N/a
BANGALORE, KARNATAKA
Uranium Corporation Of India Limited
CUDDAPAH, ANDHRA PRADESH
Tender Results
Loading results...
Title1
Atropine Sulphate 0.6 mg, 1 ml Inj
Title2
Paracetamol with cysteine HCL monohydrate Infusion 1000mg/100ml
Title3
Common Cold Tab (Cetrizine 5-10 + Paracetamol 500 mg +pseudoephedrine 30-60mg)
Title4
Naproxen 250mg Tab
Title5
Adrenaline Tartrate 1 1000 1 ml Inj
Title6
Pregabalin 75 mg plus Methylcobalamine 1500mcg Tab
Title7
Hydrocortisone Sodium Succininate 100 mg Inj
Title8
Pheniramine Maleate Inj 22point75 mg per ml amp of 2 ml
Title9
Sumatriptan 50 mg Tab
Title10
Tab Telmisartan 80 mg plus Amlodipine 5 mg
Title11
Paracetamol 150 mgperml 2 ml IV inj
Title12
Ondansetron 8 mg Tab
Title13
Folic Acid 5 mg Tab
Title14
Lignocaine HCl solution 2% for IV use 50 ml Inj
Title15
Syp Zinc 20 mgper5 ml Bottle of 100 ml
Title16
Troponin T Test card
Title17
Aspirin 75 mg Tab
Title18
Syp Cough Pediatric containing levosalbutamol sulphate ambroxol hydrochloride and guaiphenesin expectorant bott of 100 ml
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Title1 | Atropine Sulphate 0.6 mg, 1 ml Inj | 30 | amp | buyer1@401 | 28 | |
| 2 | Title2 | Paracetamol with cysteine HCL monohydrate Infusion 1000mg/100ml | 42 | bott | buyer1@401 | 28 | |
| 3 | Title3 | Common Cold Tab (Cetrizine 5-10 + Paracetamol 500 mg +pseudoephedrine 30-60mg) | 12,000 | no | buyer1@401 | 28 | |
| 4 | Title4 | Naproxen 250mg Tab | 800 | no | buyer1@401 | 28 | |
| 5 | Title5 | Adrenaline Tartrate 1 1000 1 ml Inj | 27 | amp | buyer1@401 | 28 | |
| 6 | Title6 | Pregabalin 75 mg plus Methylcobalamine 1500mcg Tab | 1,200 | no | buyer1@401 | 28 | |
| 7 | Title7 | Hydrocortisone Sodium Succininate 100 mg Inj | 200 | vial | buyer1@401 | 28 | |
| 8 | Title8 | Pheniramine Maleate Inj 22point75 mg per ml amp of 2 ml | 300 | amp | buyer1@401 | 28 | |
| 9 | Title9 | Sumatriptan 50 mg Tab | 300 | no | buyer1@401 | 28 | |
| 10 | Title10 | Tab Telmisartan 80 mg plus Amlodipine 5 mg | 300 | no | buyer1@401 | 28 | |
| 11 | Title11 | Paracetamol 150 mgperml 2 ml IV inj | 200 | amp | buyer1@401 | 28 | |
| 12 | Title12 | Ondansetron 8 mg Tab | 3,600 | no | buyer1@401 | 28 | |
| 13 | Title13 | Folic Acid 5 mg Tab | 5,700 | no | buyer1@401 | 28 | |
| 14 | Title14 | Lignocaine HCl solution 2% for IV use 50 ml Inj | 3 | vial | buyer1@401 | 28 | |
| 15 | Title15 | Syp Zinc 20 mgper5 ml Bottle of 100 ml | 200 | bott | buyer1@401 | 28 | |
| 16 | Title16 | Troponin T Test card | 15 | no | buyer1@401 | 28 | |
| 17 | Title17 | Aspirin 75 mg Tab | 1,600 | no | buyer1@401 | 28 | |
| 18 | Title18 | Syp Cough Pediatric containing levosalbutamol sulphate ambroxol hydrochloride and guaiphenesin expectorant bott of 100 ml | 400 | bott | buyer1@401 | 28 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | JP TRADERS Under PMA | - | 04-01-2025 17:10:37 | |
| 2 | KR-ONE PHARMA Under PMA | - | 11-01-2025 17:57:40 | |
| 3 | Pankaj Enterprises Under PMA | - | 02-01-2025 19:48:40 | |
| 4 | ROYAL BIOTECH Under PMA | - | 17-01-2025 18:11:50 | |
| 5 | Saviour Biotech Inc Under PMA | - | 17-01-2025 18:09:53 | |
| 6 | SUNIL PHARMACY Under PMA | - | 17-01-2025 18:30:49 |
| Rank | Seller | Price | Item |
|---|---|---|---|
| L1 | ROYAL BIOTECH(MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl | |
| L2 | Saviour Biotech Inc (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl | |
| L3 | SUNIL PHARMACY (MSE,MII)( MSE Social Category:General ) Under PMA | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl | |
| L4 | Pankaj Enterprises (MII) Under PMA | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl | |
| L5 | JP TRADERS (MII) Under PMA | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl | |
| L6 | KR-ONE PHARMA (MII) Under PMA | Item Categories : Title1,Title2,Title3,Title4,Title5,Title6,Title7,Title8,Title9,Title10,Title11,Title12,Title13,Titl |
Key insights about PUNJAB tender market
The eligibility requirements include being a registered entity with a proven track record of at least three years of experience in supplying medical products. Bidders seeking exemptions from these criteria must submit supporting documents to validate their eligibility.
Bidders are required to possess certifications such as OEM Authorizations, experience documentation, and compliance certificates relevant to the items listed in the BoQ. These documents ensure adherence to quality and specification standards.
To register for participation, bidders must create an account on the GeM portal and provide relevant business details. All necessary documents must then be prepared for submission in line with the guidelines specified in the tender documentation.
All documents submitted must comply with the specified formats outlined in the tender. Typically, accepted formats include PDF for documentation and spreadsheet formats where quantitative data is necessitated.
Technical specifications demand that all medical supplies meet the standards set forth in the BoQ. Bidders will need to demonstrate compliance with these specifications through relevant documentation.
Yes, all submitted products must meet national quality standards for medical supplies. Bidders must provide validation documents to prove that their products comply with these standards.
Bidders must comply with all regulatory requirements set by the Ministry of Defence and the Department of Military Affairs. This includes adherence to quality specifications, eligibility documentation, and any other prescribed conditions outlined in the tender.
While the tender documentation does not specify an inspection requirement, bidders are expected to ensure that the products meet the quality benchmarks before delivery, as indicated in compliance documents submitted.
The EMD specifics should be referred to in the tender documentation; it typically involves an initial deposit to secure the bid submission and ensure serious participation in the tender process.
Successful bidders may be required to submit a performance security as a guarantee for the execution of the contract. Details related to performance security terms will be disclosed upon awarding the contract.
Payment terms typically involve milestone payments subject to delivery schedules and compliance with contract requirements. Specific terms will be detailed within the awarded contract documentation.
Price evaluations will be conducted based on the total value-wise evaluation method, considering both the competitiveness and compliance with the financial requirements established in the tender submission.
Bidders must submit their proposals through the GeM portal in accordance with the submission guidelines. It is essential to adhere strictly to the submission process outlined in the tender document.
Key timelines include the bid opening date and the closing date for submissions, which should be referenced directly in the tender documentation to ensure timely participation.
Notification of results will be communicated through the GeM portal, where bidders can log in to view the outcomes of the selection process. It is essential for bidders to regularly check for updates post-submission.
MSEs are eligible for exemptions regarding experience requirements, which aids in promoting their competitive bidding capabilities.
Yes, the tender includes provisions aimed at facilitating the participation of startups, encouraging innovation and diversity in the supplier base as per government initiatives.
This tender promotes local sourcing and manufacturing by encouraging participation from domestic suppliers, aligning with the 'Make in India' initiative to boost local economic growth and development.
Uttar Pradesh Rajya Vidyut Utpadan Nigam Limited (uprvunl) Lucknow
📍 ALIGARH, UTTAR PRADESH
Tourism Secretariate
📍 NEW DELHI, DELHI
Airports Authority Of India ,rhq Nr - Rangpuri
📍 WEST DELHI, DELHI
Indian Coast Guard
📍 DAKSHINA KANNADA, KARNATAKA
Western Regional Power Committee (wrpc)
📍 MUMBAI, MAHARASHTRA
Sign up now to access all documents
Main Document
BOQ
BOQ
GEM_GENERAL_TERMS_AND_CONDITIONS